ML 161

  Cat. No.:  DC7197   Featured
Chemical Structure
423735-93-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). Thought to act allosterically. Also inhibits thrombin-induced platelet activation.
Cas No.: 423735-93-7
Chemical Name: 2-Bromo-N-(3-butyramidophenyl)benzamide
Synonyms: 2-Bromo-N-(3-butyramidophenyl)benzamide;ML 161;2-bromo-N-[3-(butanoylamino)phenyl]benzamide;ML-161;2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]-benzamide;ML161;2-Bromo-N-[3-[(1-oxobutyl)amino]phenyl]benzamide;2-bromo-N-[3-(butyrylamino)phenyl]benzamide;AK142591;SMR000193713;MLS000571703;Cambridge id 5946339;Oprea1_852187;MLS002699906;ARONIS27179;AOB1565;DFOVLSMXPWPCFH-UHFFFAOYSA-N;HMS3651N10;BENZAMIDE, 2-BROMO-N-[3-[(1-OXOBUTYL)AMINO]PHENYL]-;HMS2461M06;BC;Parmodulin 2;2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide;BENZAMIDE, 2-BROMO-N-[3-[
SMILES: BrC1=C([H])C([H])=C([H])C([H])=C1C(N([H])C1=C([H])C([H])=C([H])C(=C1[H])N([H])C(C([H])([H])C([H])([H])C([H])([H])[H])=O)=O
Formula: C17H17BrN2O2
M.Wt: 361.2331
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: Parmodulin 2 (ML161),a probe, is an allosteric inhibitor of protease-activated receptor 1 (PAR1) with an IC50 of 0.26 μM. Parmodulin 2 inhibits platelet aggregation induced by a PAR1 peptide agonist or by thrombin and has shown cytoprotective effects[1, 2].
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC8860 Vorapaxar Vorapaxar (SCH 530348) is a potent and orally active thrombin receptor (PAR-1) antagonist with Ki of 8.1 nM.
DC7197 ML 161 Inhibitor of protease-activated receptor 1 (PAR1)-mediated platelet activation (IC50 = 0.26 μM for the inhibition of platelet P-selectin expression on human platelets). Thought to act allosterically. Also inhibits thrombin-induced platelet activation.
DC11923 BMS-986120 BMS-986120 (BMS986120) is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4.
DC10879 AZ3451 AZ3451 is a potent and selective allosteric antagonist of protease-activated receptor 2 (PAR2)
X